End-of-day quote
INDONESIA S.E.
18:00:00 2024-05-30 EDT
|
5-day change
|
1st Jan Change
|
90
IDR
|
-.--%
|
|
-7.22%
|
-3.23%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
20.35
|
24.92
|
12.73
|
10.63
|
11.87
|
14.35
|
Enterprise Value (EV)
1 |
135.6
|
141
|
129.5
|
119.5
|
100.9
|
79.34
|
P/E ratio
|
-3.79
x
|
186
x
|
-1.98
x
|
-1.82
x
|
1.69
x
|
7.92
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.15
x
|
0.15
x
|
0.12
x
|
0.1
x
|
0.07
x
|
0.08
x
|
EV / Revenue
|
0.98
x
|
0.87
x
|
1.2
x
|
1.1
x
|
0.64
x
|
0.43
x
|
EV / EBITDA
|
10.8
x
|
6.37
x
|
10.9
x
|
7.41
x
|
2.96
x
|
2.59
x
|
EV / FCF
|
51.8
x
|
32.1
x
|
39.8
x
|
11.1
x
|
5.99
x
|
13
x
|
FCF Yield
|
1.93%
|
3.11%
|
2.51%
|
9.01%
|
16.7%
|
7.7%
|
Price to Book
|
-18
x
|
-6.61
x
|
-1.22
x
|
-0.76
x
|
-1.52
x
|
1.35
x
|
Nbr of stocks (in thousands)
|
1,765,928
|
1,765,928
|
1,765,928
|
1,765,928
|
1,765,928
|
2,373,449
|
Reference price
2 |
0.0115
|
0.0141
|
0.007210
|
0.006020
|
0.006720
|
0.006045
|
Announcement Date
|
4/2/19
|
4/20/20
|
6/18/21
|
4/21/22
|
4/10/23
|
4/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
137.7
|
161.8
|
108.3
|
108.9
|
158.3
|
185.1
|
EBITDA
1 |
12.61
|
22.12
|
11.87
|
16.12
|
34.11
|
30.66
|
EBIT
1 |
6.18
|
15.71
|
5.556
|
7.732
|
28.43
|
26.19
|
Operating Margin
|
4.49%
|
9.71%
|
5.13%
|
7.1%
|
17.96%
|
14.15%
|
Earnings before Tax (EBT)
1 |
-6.201
|
0.8591
|
-4.2
|
-3.528
|
21.59
|
14.44
|
Net income
1 |
-5.367
|
0.1351
|
-6.44
|
-5.755
|
7.004
|
1.442
|
Net margin
|
-3.9%
|
0.08%
|
-5.95%
|
-5.29%
|
4.42%
|
0.78%
|
EPS
2 |
-0.003039
|
0.000076
|
-0.003646
|
-0.003300
|
0.003965
|
0.000763
|
Free Cash Flow
1 |
2.621
|
4.389
|
3.251
|
10.76
|
16.85
|
6.107
|
FCF margin
|
1.9%
|
2.71%
|
3%
|
9.88%
|
10.64%
|
3.3%
|
FCF Conversion (EBITDA)
|
20.78%
|
19.84%
|
27.39%
|
66.73%
|
49.4%
|
19.92%
|
FCF Conversion (Net income)
|
-
|
3,247.56%
|
-
|
-
|
240.58%
|
423.38%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/2/19
|
4/20/20
|
6/18/21
|
4/21/22
|
4/10/23
|
4/18/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
115
|
116
|
117
|
109
|
89
|
65
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
9.141
x
|
5.246
x
|
9.839
x
|
6.75
x
|
2.61
x
|
2.12
x
|
Free Cash Flow
1 |
2.62
|
4.39
|
3.25
|
10.8
|
16.8
|
6.11
|
ROE (net income / shareholders' equity)
|
-40.7%
|
9.47%
|
-108%
|
-449%
|
270%
|
30.7%
|
ROA (Net income/ Total Assets)
|
2.06%
|
5.17%
|
1.91%
|
2.86%
|
10.3%
|
9.04%
|
Assets
1 |
-261
|
2.613
|
-336.4
|
-201
|
67.94
|
15.96
|
Book Value Per Share
2 |
-0
|
-0
|
-0.0100
|
-0.0100
|
-0
|
0
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0
|
Capex
1 |
2.07
|
2.78
|
1.02
|
2.73
|
2.94
|
6.2
|
Capex / Sales
|
1.5%
|
1.72%
|
0.94%
|
2.51%
|
1.86%
|
3.35%
|
Announcement Date
|
4/2/19
|
4/20/20
|
6/18/21
|
4/21/22
|
4/10/23
|
4/18/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.23% | 13.15M | | +2.46% | 102B | | -8.98% | 60.79B | | +74.76% | 48.86B | | +13.97% | 37.96B | | +4.56% | 32.37B | | +14.72% | 20.64B | | +11.17% | 16.58B | | +8.81% | 13.93B | | -3.19% | 13.25B |
Other Commodity Chemicals
|